Eli Lilly and Company logo

Eli Lilly and Company - LLY

NYSE:LLY · ISIN US5324571083
StockHealthcareDrug Manufacturers - General🇺🇸 US

Eli Lilly and Company stock, tokenized as LLY.d by Dinari Inc., LLYon by Ondo Finance and LLYx by Backed Finance. Trades 24/7 on supported chains; redeemable 1:1 for the underlying with each issuer.

NYSE
$1,131.42
+0.55%+$6.15 today
Issued byOndo FinanceBacked FinanceDinari Inc.

About

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. Headquartered in Indianapolis, Indiana, the company focuses on therapies addressing diabetes, oncology, immunology, neuroscience, and cardiometabolic conditions. Its portfolio includes medicines for chronic metabolic diseases, cancer treatments aimed at specific tumor types, and immunology drugs targeting inflammatory and autoimmune disorders. Eli Lilly and Company serves healthcare systems, hospitals, and pharmacies worldwide, with a strong presence in major markets such as the United States, Europe, China, and Japan. The company operates across the full pharmaceutical value chain, from research and clinical development to large-scale manufacturing and global distribution. Through its focus on innovative, science-driven therapies for complex diseases, Eli Lilly and Company plays a significant role in the healthcare sector, supporting physicians and patients with branded medicines that are integrated into standard treatment protocols across multiple therapeutic areas.

Underlying metrics
Market cap$1T
Tokenized market cap$5.5M<0.01% of mkt cap
P/E (trailing)40.16
P/E (forward)25.43
EPS (TTM)$28.17
Beta0.52
Div. yield (fwd)0.61%
Div. yield (TTM)0.57%
Div. frequencyQuarterly
Ex-div dateMay 15, 2026
52-week range$623.78 — $1,166.29
Avg volume (90d)3.5M
Price/sales13.96
PEG ratio0.24
Providers and contracts

Similar products